Tao Xi
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 29
- MicroRNA in disease regulation 28
- Molecular Biology top 2%
- Circular RNAs in diseases 15
- RNA modifications and cancer 14
- RNA Research and Splicing 12
- Microbiology top 2%
- Antimicrobial Peptides and Activities 13
- Immunology top 5%
- Galectins and Cancer Biology 12
- Hepatology top 2%
-
- Helicobacter pylori-related gastroenterology studies 19
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (2 papers)Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Tao Xi
217 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 2.2k
- Molecular Biology 3.9k
- Microbiology 271
- Immunology 866
- Hepatology 314
Countries citing papers authored by Tao Xi
This map shows the geographic impact of Tao Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Xi more than expected).
Fields of papers citing papers by Tao Xi
This network shows the impact of papers produced by Tao Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Xi. The network helps show where Tao Xi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 6 | |
| 7 | Teacher support in learning: Instrumental and appraisal support in relation to math achievement | 2018 | 39 |
| 8 | 2017 | 33 | |
| 9 | Iterative Innovation Design Methods of Internet Products in the Era of Big Data | 2016 | 2 |
| 10 | 2013 | 38 | |
| 11 | The Antioxidant Activities of Extracellular Polysaccharides from Arctic Streptomyces sp.T-2-3 in vitro | 2012 | 0 |
| 12 | Activity of S-thanatin Thanatin Analog against Multidrug-Resistant Gram-Negative Organisms In Vitro and The synergy with 7 kinds of Antibiotics | 2009 | 1 |
| 13 | 2009 | 2 | |
| 14 | In Vitro Anticancer Activities of Different Extraction Parts from the Stems and Leaves of Humulus Lupulus L. and Identification of the Chemical Constituents Therein | 2009 | 2 |
| 15 | Expression and Purification of Antimicrobial Peptide s-Thanatin in Escherichia coli | 2009 | 1 |
| 16 | Anti-migration and anti-angiogenic effects of tanshinone IIA on breast cancer cell MDA-MB-435. | 2009 | 4 |
| 17 | Suppression of SMYD3 expression in HeLa cells by an inducible shRNAs expression system | 2007 | 1 |
| 18 | Biological activity of human endostatin-derived synthetic peptide——Es-2 | 2006 | 1 |
| 19 | Preliminary study on the antiradiation effect of intracellular grifolan come from grifola frondosa | 2003 | 1 |
| 20 | The pharmacodynamic studies of Ginkgo biloba extract on diabetes mellitus | 2000 | 2 |
About Tao Xi
Tao Xi is a scholar working on Cancer Research, Microbiology and Immunology, having authored 226 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (29 papers), MicroRNA in disease regulation (28 papers), Helicobacter pylori-related gastroenterology studies (19 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (14 papers), Antimicrobial Peptides and Activities (13 papers), RNA Research and Splicing (12 papers) and Galectins and Cancer Biology (12 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (3.9k citations) and Microbiology (271 citations). Tao Xi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lufeng Zheng, Yingying Xing, Xiaoman Li, Haiwei Ni, Le Guo, Qianqian Guo, Xiaobo Lv, Yingying Xing, Kunmei Liu and Jing Xiong. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.